Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
about
A systematic review and meta-analysis of anti-adhesion molecule therapy in patients with active Crohn's disease.The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patientsImpact of pain on health-related quality of life in patients with inflammatory bowel diseaseThe impact of biologics on health-related quality of life in patients with inflammatory bowel disease.Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumabEffects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialMechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.Anti-adhesion molecule therapy for inflammatory bowel diseaseAn evidence-based systematic review on medical therapies for inflammatory bowel disease.Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.New biologic therapeutics for ulcerative colitis and Crohn's disease.The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review.The role of integrin antagonists in the treatment of inflammatory bowel disease.Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation.The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.Therapeutic Targets for Emerging Biologic Therapies in IBD.Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.
P2860
Q33514539-2DC40BD6-C5AB-4129-839A-3F65BEC9C104Q33536129-FF04C6B9-E6A0-4C14-B24B-009717004B2AQ33960394-202A1F61-67D2-4A13-9FDB-8FE0CA3C5ACEQ35026298-65007789-1B8C-469A-A92C-FA0DC148E787Q35205472-67A6EF8A-1B24-42F7-8137-6F028CE8618FQ37561775-B7DC4A7A-B595-44E7-B2EF-BEC1D8A1D39BQ37680981-5D1C3243-DE53-401C-945C-3009D62F7D87Q37769253-0240236C-1141-40C9-BB06-D60E4F659311Q37823325-994B2F17-E87D-4BC2-80C6-A8747277C6F9Q37862584-7DF638CF-23F3-4DDB-A259-80080270B118Q38053495-9719FC29-4665-49E4-971B-74CE2037294CQ38185687-0D183428-59B5-4A2D-805A-92B332973580Q38254538-0F85BC68-B6F2-49C1-9D77-EF0BB04ECFB9Q38257410-9DE274E6-7C61-4EA9-8DA2-20F9995892AFQ38265958-F273BFF1-B084-421E-A733-507F5BAD3A6EQ38430984-92E50F97-785E-40A6-8272-F099A879504AQ38488635-B4811BF5-0402-487B-8145-E6A941D44717Q38895422-0B70DD55-CEAD-4726-AA79-0325B5F0BECCQ45839795-6FFBA50F-6DFB-40F7-9B9C-D9919B097304Q48106537-9D8D4F4A-F0CF-4F08-B673-7626A9B343D0
P2860
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@ast
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@en
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@nl
type
label
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@ast
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@en
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@nl
prefLabel
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@ast
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@en
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@nl
P2860
P50
P1476
Health-related quality of life during natalizumab maintenance therapy for Crohn's disease
@en
P2093
Jeffrey White
Timothy Niecko
P2860
P304
P356
10.1111/J.1572-0241.2007.01508.X
P407
P577
2007-12-01T00:00:00Z